Literature DB >> 15100310

Arthritogenic properties of double-stranded (viral) RNA.

Fariba Zare1, Maria Bokarewa, Nancy Nenonen, Thomas Bergström, Lena Alexopoulou, Richard A Flavell, Andrej Tarkowski.   

Abstract

Viral infections often lead to arthralgias and overt arthritic states. The inflammatogenic compound of the viruses giving rise to such an outcome has to date not been identified. Because expression of dsRNA is a common feature of all viruses, we decided to analyze whether this property leads to the induction of arthritis. Histological signs of arthritis were evident already on day 3 following intra-articular administration of dsRNA. Arthritis was characterized by infiltration of macrophages into synovial tissue. It was not dependent on acquired immune responses because SCID mice also raised joint inflammation. NF-kappa B was activated upon in vitro exposure to dsRNA, indicating its role in the induction/progression of arthritis. Importantly, we found that dsRNA arthritis was triggered through IL-1R signaling because mice being deficient for this molecule were unable to develop joint inflammation. Although dsRNA is typically recognized by Toll-like receptor 3, Toll-like receptor 3 knockout mice developed arthritis, indicating that some other receptors are instrumental in the inducing of inflammation. Our results from in vitro experiments indicate that proinflammatory cytokines and chemokines stimulating monocyte influx were readily triggered in response to stimulation with dsRNA. These findings demonstrate that viral dsRNA is clearly arthritogenic. Importantly, macrophages and their products play an important role in the development of arthritis triggered by dsRNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100310     DOI: 10.4049/jimmunol.172.9.5656

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis.

Authors:  Thomas E Morrison; Alan C Whitmore; Reed S Shabman; Brett A Lidbury; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.

Authors:  Susan E Sweeney; Trevor B Kimbler; Gary S Firestein
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

Review 3.  Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.

Authors:  Leo A B Joosten; Shahla Abdollahi-Roodsaz; Charles A Dinarello; Luke O'Neill; Mihai G Netea
Journal:  Nat Rev Rheumatol       Date:  2016-05-12       Impact factor: 20.543

Review 4.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

Review 5.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

6.  Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.

Authors:  Jun P Hong; Mary K McCarthy; Bennett J Davenport; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

7.  Characterization, promoter analysis and expression of the interleukin-6 gene in blunt snout bream, Megalobrama amblycephala.

Authors:  Xiaoqin Fu; Zhujin Ding; Jun Fan; Huanling Wang; Fengjuan Zhou; Lei Cui; Chen Boxiang; Weimin Wang; Hong Liu
Journal:  Fish Physiol Biochem       Date:  2016-05-28       Impact factor: 2.794

Review 8.  The role of toll-like receptors in rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

9.  Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.

Authors:  Su-Jin Moon; Mi-Kyung Park; Hye-Jwa Oh; Seon-Yeong Lee; Seung-Ki Kwok; Mi-La Cho; Ji Hyeon Ju; Kyung-Su Park; Ho-Youn Kim; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.